Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James B Bussel

Showing results (181-190 of 262) with videos related to

Pageof 27
Sort By:
Lancet (London, England)|August 27, 2010
Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 studyGregory Cheng, Mansoor N Saleh, Claus Marcher, et al.
British Journal of Haematology|May 19, 2026
Fetal and neonatal alloimmune thrombocytopenia (FNAIT): Survey of UK fetal medicine centres on antenatal management of subsequent affected pregnanciesAsha Aggarwal, Catherine Prodger, Brian Hockley, et al.
British Journal of Haematology|June 5, 2007
The immune thrombocytopenic purpura (ITP) bleeding score: assessment of bleeding in patients with ITPLemke K Page, Bethan Psaila, Drew Provan, et al.
Pediatric Blood & Cancer|October 28, 2014
Long-term use of the thrombopoietin-mimetic romiplostim in children with severe chronic immune thrombocytopenia (ITP)James B Bussel, Loan Hsieh, George R Buchanan, et al.
British Journal of Haematology|February 27, 2004
Intravenous (IV) anti-D and IV immunoglobulin achieve acute platelet increases by different mechanisms: modulation of cytokine and platelet responses to IV anti-D by FcgammaRIIa and FcgammaRIIIa polymorphismsNichola Cooper, Nancy M Heddle, Masja Haas, et al.
Haematologica|March 9, 2019
Long-term treatment with romiplostim and treatment-free platelet responses in children with chronic immune thrombocytopeniaMichael D Tarantino, James B Bussel, Victor S Blanchette, et al.
Blood|October 24, 2008
Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic reviewRoberto Stasi, Ameet Sarpatwari, Jodi B Segal, et al.
American Journal of Obstetrics and Gynecology|June 29, 2025
Increased frequency of autism by previous diagnosis and screening in children with fetal-neonatal alloimmune thrombocytopenia with and without an intracranial hemorrhageEleanore A McFarland, Katherine A Knightly, Emilie Vander Haar, et al.
Thrombosis and Haemostasis|March 27, 2004
IGIV-C, a novel intravenous immunoglobulin: evaluation of safety, efficacy, mechanisms of action, and impact on quality of lifeJames B Bussel, Amiram Eldor, John G Kelton, et al.
American Journal of Hematology|May 7, 2019
Maternal sensitization occurs before delivery in severe cases of fetal alloimmune thrombocytopeniaJenny C Jin, Madhavi M Lakkaraja, Polina Ferd, et al.
Pageof 27

Showing results (181-190 of 262) with videos related to

Sort By:
Pageof 27
Lancet (London, England)|August 27, 2010
Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 studyGregory Cheng, Mansoor N Saleh, Claus Marcher, et al.
British Journal of Haematology|May 19, 2026
Fetal and neonatal alloimmune thrombocytopenia (FNAIT): Survey of UK fetal medicine centres on antenatal management of subsequent affected pregnanciesAsha Aggarwal, Catherine Prodger, Brian Hockley, et al.
British Journal of Haematology|June 5, 2007
The immune thrombocytopenic purpura (ITP) bleeding score: assessment of bleeding in patients with ITPLemke K Page, Bethan Psaila, Drew Provan, et al.
Pediatric Blood & Cancer|October 28, 2014
Long-term use of the thrombopoietin-mimetic romiplostim in children with severe chronic immune thrombocytopenia (ITP)James B Bussel, Loan Hsieh, George R Buchanan, et al.
British Journal of Haematology|February 27, 2004
Intravenous (IV) anti-D and IV immunoglobulin achieve acute platelet increases by different mechanisms: modulation of cytokine and platelet responses to IV anti-D by FcgammaRIIa and FcgammaRIIIa polymorphismsNichola Cooper, Nancy M Heddle, Masja Haas, et al.
Haematologica|March 9, 2019
Long-term treatment with romiplostim and treatment-free platelet responses in children with chronic immune thrombocytopeniaMichael D Tarantino, James B Bussel, Victor S Blanchette, et al.
Blood|October 24, 2008
Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic reviewRoberto Stasi, Ameet Sarpatwari, Jodi B Segal, et al.
American Journal of Obstetrics and Gynecology|June 29, 2025
Increased frequency of autism by previous diagnosis and screening in children with fetal-neonatal alloimmune thrombocytopenia with and without an intracranial hemorrhageEleanore A McFarland, Katherine A Knightly, Emilie Vander Haar, et al.
Thrombosis and Haemostasis|March 27, 2004
IGIV-C, a novel intravenous immunoglobulin: evaluation of safety, efficacy, mechanisms of action, and impact on quality of lifeJames B Bussel, Amiram Eldor, John G Kelton, et al.
American Journal of Hematology|May 7, 2019
Maternal sensitization occurs before delivery in severe cases of fetal alloimmune thrombocytopeniaJenny C Jin, Madhavi M Lakkaraja, Polina Ferd, et al.
Pageof 27